We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YDKG
3626
Yueda Digital Holding
YDKG
$5.97M
$3.67K ﹤0.01%
46
LGHL
3627
Lion Group Holding
LGHL
$831K
0
AMRN
3628
Amarin Corp
AMRN
$303M
$3.6K ﹤0.01%
207
+127
+159% +$1.99K
JFU
3629
9F Inc
JFU
$29M
$3.51K ﹤0.01%
1,034
GIFI
3630
DELISTED
Gulf Island Fabrication
GIFI
$3.46K ﹤0.01%
800
AQN icon
3631
Algonquin Power & Utilities
AQN
$4.42B
$3.44K ﹤0.01%
544
FIRY
3632
Firy Inc
FIRY
$163M
$3.41K ﹤0.01%
546
VRM icon
3633
Vroom Inc
VRM
$48.2M
$3.4K ﹤0.01%
71
-39
-35% -$2.55K
PRAX icon
3634
Praxis Precision Medicines
PRAX
$10.1B
$3.39K ﹤0.01%
152
APYX icon
3635
Apyx Medical
APYX
$171M
$3.36K ﹤0.01%
1,284
LFVN icon
3636
LifeVantage
LFVN
$85.3M
$3.34K ﹤0.01%
556
CVM icon
3637
CEL-SCI Corp
CVM
$30.1M
$3.32K ﹤0.01%
41
YQ
3638
17 Education & Technology Group
YQ
$23.2M
$3.18K ﹤0.01%
1,545
-1
-0.1% -$3
VXRT
3639
DELISTED
Vaxart
VXRT
$3.17K ﹤0.01%
5,526
EARN
3640
Ellington Residential Mortgage REIT
EARN
$165M
$3.14K ﹤0.01%
513
GOSS icon
3641
Gossamer Bio
GOSS
$87M
$3.11K ﹤0.01%
3,404
HYZN
3642
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$3.1K ﹤0.01%
69
SCNI
3643
Scinai Immunotherapeutics
SCNI
$1.27M
$3.08K ﹤0.01%
531
+176
+50% +$1.21K
UPLD icon
3644
Upland Software
UPLD
$15.4M
$3.08K ﹤0.01%
73
EXPR
3645
DELISTED
Express, Inc.
EXPR
$3.04K ﹤0.01%
363
TRML
3646
DELISTED
Tourmaline Bio
TRML
$3.04K ﹤0.01%
116
XBIT icon
3647
XBiotech
XBIT
$69.2M
$3.01K ﹤0.01%
753
NKTR icon
3648
Nektar Therapeutics
NKTR
$2.58B
$3.01K ﹤0.01%
355
KORE
3649
DELISTED
KORE Group Holdings
KORE
$2.98K ﹤0.01%
607
GTHX
3650
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2.95K ﹤0.01%
967

Similar funds

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.